[go: up one dir, main page]

MX2014001368A - Soluciones anti-inflamatorias estables para inyección. - Google Patents

Soluciones anti-inflamatorias estables para inyección.

Info

Publication number
MX2014001368A
MX2014001368A MX2014001368A MX2014001368A MX2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A MX 2014001368 A MX2014001368 A MX 2014001368A
Authority
MX
Mexico
Prior art keywords
injection
stable anti
inflammatory
inflammatory solutions
solutions
Prior art date
Application number
MX2014001368A
Other languages
English (en)
Other versions
MX347373B (es
Inventor
Wayne R Gombotz
Gregory A Demopulos
Hui-Rong Shen
Original Assignee
Omeros Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47627326&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014001368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omeros Corp filed Critical Omeros Corp
Publication of MX2014001368A publication Critical patent/MX2014001368A/es
Publication of MX347373B publication Critical patent/MX347373B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente invención se relaciona con formulaciones de líquido estable de ketoprofeno, amitriptilina y oximetazolina.
MX2014001368A 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección. MX347373B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161515234P 2011-08-04 2011-08-04
PCT/US2012/049463 WO2013020021A1 (en) 2011-08-04 2012-08-03 Stable anti-inflammatory solutions for injection

Publications (2)

Publication Number Publication Date
MX2014001368A true MX2014001368A (es) 2014-06-11
MX347373B MX347373B (es) 2017-04-25

Family

ID=47627326

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014001368A MX347373B (es) 2011-08-04 2012-08-03 Soluciones anti-inflamatorias estables para inyección.

Country Status (20)

Country Link
US (3) US20130035362A1 (es)
EP (1) EP2739266B1 (es)
JP (2) JP6174579B2 (es)
KR (1) KR101951064B1 (es)
CN (1) CN103957886B (es)
AR (1) AR089203A1 (es)
AU (1) AU2012289968B2 (es)
BR (1) BR112014002631B1 (es)
CA (1) CA2844152C (es)
CL (1) CL2014000267A1 (es)
DK (1) DK2739266T3 (es)
ES (1) ES2600153T3 (es)
IL (1) IL230779B (es)
MX (1) MX347373B (es)
NZ (1) NZ621484A (es)
PL (1) PL2739266T3 (es)
PT (1) PT2739266T (es)
RU (1) RU2635521C2 (es)
WO (1) WO2013020021A1 (es)
ZA (1) ZA201401344B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201707528WA (en) 2013-03-15 2017-10-30 Tonix Pharmaceuticals Inc Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
WO2016014408A1 (en) * 2014-07-21 2016-01-28 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US20170049134A1 (en) * 2015-08-18 2017-02-23 Empire Technology Development Llc Meat tendering using food grade natural products for reducing muscle contraction
WO2020188457A1 (en) 2019-03-15 2020-09-24 Ftf Pharma Private Limited Solutions for oral dosage
FR3108841B1 (fr) 2020-04-06 2023-11-03 Algotherapeutix Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline
FR3123563B1 (fr) * 2021-06-03 2025-02-14 Algotherapeutix Utilisation de l’amitriptyline et/ou l’un de ses sels pharmaceutiquement acceptable comme agent conservateur
CN116165306B (zh) * 2023-04-25 2023-11-17 湖南九典制药股份有限公司 酮洛芬凝胶贴膏中有关物质的分析测定方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
IT1269583B (it) * 1994-04-26 1997-04-08 Bayer Italia Spa Preparazioni farmaceutiche a base di una soluzione di ketoprofene in capsule di gelatina molle e metodo per la loro produzione
ES2377126T3 (es) * 1994-12-12 2012-03-22 Omeros Corporation Solución de irrigación y utilización de la misma para la inhibición perioperatoria del dolor, la inflamación y/o los espasmos en una estructura vascular
US7091181B2 (en) * 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
US7973068B2 (en) * 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
KR20120099730A (ko) * 2005-05-20 2012-09-11 오메로스 코포레이션 시클로옥시게나제 저해제 및 칼슘채널 길항제 조성물 및 이의 비뇨기과 시술시의 용도를 위한 방법
WO2007103687A2 (en) * 2006-03-01 2007-09-13 Tristrata, Inc. Composition and method for topical treatment of tar-responsive dermatological disorders
WO2008098019A2 (en) * 2007-02-05 2008-08-14 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
WO2008115572A1 (en) * 2007-03-21 2008-09-25 Theraquest Biosciences, Inc. Methods and compositions of nsaids
CN107007546A (zh) * 2011-02-15 2017-08-04 阿勒根公司 用于治疗红斑痤疮的症状的羟甲唑啉药物乳膏组合物

Also Published As

Publication number Publication date
KR101951064B1 (ko) 2019-02-21
DK2739266T3 (en) 2016-10-03
IL230779A0 (en) 2014-03-31
BR112014002631B1 (pt) 2022-04-19
RU2014108159A (ru) 2015-09-10
PL2739266T3 (pl) 2017-07-31
WO2013020021A1 (en) 2013-02-07
ZA201401344B (en) 2016-10-26
BR112014002631A2 (pt) 2017-03-07
CN103957886B (zh) 2016-03-30
EP2739266B1 (en) 2016-07-27
US20160166696A1 (en) 2016-06-16
CL2014000267A1 (es) 2014-08-29
EP2739266A4 (en) 2014-12-31
AU2012289968A1 (en) 2013-03-28
US20130035362A1 (en) 2013-02-07
JP6174579B2 (ja) 2017-08-02
CA2844152A1 (en) 2013-02-07
HK1198911A1 (en) 2015-06-19
KR20140057579A (ko) 2014-05-13
EP2739266A1 (en) 2014-06-11
AR089203A1 (es) 2014-08-06
PT2739266T (pt) 2016-10-04
NZ621484A (en) 2016-05-27
CA2844152C (en) 2020-04-14
JP2017014288A (ja) 2017-01-19
AU2012289968B2 (en) 2014-01-16
IL230779B (en) 2019-05-30
US20180344855A1 (en) 2018-12-06
JP2014521694A (ja) 2014-08-28
MX347373B (es) 2017-04-25
CN103957886A (zh) 2014-07-30
RU2635521C2 (ru) 2017-11-13
ES2600153T3 (es) 2017-02-07

Similar Documents

Publication Publication Date Title
JOP20180103A1 (ar) مركب صيدلاني
EA201590807A1 (ru) Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций
UY34587A (es) Formulaciones estabilizadas que contienen anticuerpos antiang2
MX2014001368A (es) Soluciones anti-inflamatorias estables para inyección.
CO6852068A2 (es) Formulación líquida estable de etanercept
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
DK2882850T3 (da) System for preparation of adipose-derived stem cells
UY34472A (es) Derivados modificados de 4-fenil-piridina
CR20140464A (es) Compuestos de heterociclilo
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
BR112014028334A2 (pt) derivados dipeptídicos de lisina ácido glutâmico.
BR112013025866A2 (pt) formulações com viscosidade reduzida
CO7061076A2 (es) Composición farmacéutica que contiene un derivado de dihidroquinazolina antiviralmente activo
CL2016001313A1 (es) Formulaciones listas de fertilizante líquido de bifentrina.
IL236393A0 (en) Stable formulations for parenteral injection of small molecule drugs
BR112015012062A2 (pt) composição líquida detergente aquosa estruturada com polímero
BR112014026428A2 (pt) composição detergente líquida isotrópica aquosa estruturada externamente
MX347855B (es) Derivados de anilina, su preparación y su aplicación terapéutica.
BR112014026429A2 (pt) composição detergente líquida isotrópica aquosa externamente estruturada
CO7151478A2 (es) Formulaciones estabilizadas que contienen anticuerpos anti-dll4
IL241245A (en) Bicyclo [2.2.1] acid gpr120 modulators
CR20130375A (es) Preparaciones que contienen antraquinona/formulaciones de lignina
BR112013027222A2 (pt) composição de liberação prolongada que contém peptídeos como ingrediente ativo

Legal Events

Date Code Title Description
FG Grant or registration